#None #Class Action #Pomerantz Law Firm #Ardent Health

Investor Alert: Pomerantz Law Firm's Notification on Ardent Health, Inc. Class Action Lawsuit

In an important announcement for investors, Pomerantz LLP has initiated a class action lawsuit against Ardent Health, Inc. (NYSE: ARDT). If you have incurred losses due to your investment in Ardent, this may be a significant development for you.

Background on the Lawsuit

The core of this lawsuit centers on allegations of securities fraud and other illicit business practices that may have been conducted by Ardent and certain of its senior officers and directors. This legal action has been prompted by serious concerns regarding the company's recent business performance and transparency in its financial reporting, which demands the attention of current and former investors.

Investors are urged to reach out to Danielle Peyton of Pomerantz LLP to gain further insights regarding the implications of this lawsuit. You can contact her via email at [email protected] or call at 646-581-9980. It is advised that you include relevant details such as your mailing address, phone number, and the number of shares you purchased in Ardent.

Significant Deadlines

For those looking to take an active role, the deadline to request the Court to appoint you as Lead Plaintiff is March 9, 2026. Investors who purchased or acquired shares of Ardent during the Class Period are eligible to participate. A copy of the complaint is accessible through Pomerantz Law Firm's official website, www.pomerantzlaw.com.

Recent Developments at Ardent Health

The lawsuit comes in light of troubling financial news disclosed on November 12, 2025, when Ardent reported a staggering $43 million drop in its third-quarter revenue. This decline was associated with the company's transition to a new revenue accounting system, which is named the Kodiak RCA net revenue platform. This new system was supposedly designed to offer more precise evaluations regarding the collectability of accounts receivable.

Ardent’s management indicated that they are now capable of assessing reserves earlier in an account's lifecycle—a significant change from previously used measures. The new strategy was adopted after comprehensive evaluations into historical collection trends and situations concerning payer denials. This adjustment in accounting has led to a reduction in the company's 2025 EBITDA guidance by roughly 9.6%, reflecting ongoing cost pressures faced by the healthcare sector.

Moreover, the company indicated an increase of $54 million in professional liability reserves attributed to various litigation issues dating from between 2019 and 2022, particularly concerning settlements in New Mexico. This news led to a dramatic plummet in Ardent's stock price, with shares dropping by $4.75, or over 33%, to close at $9.30 on November 13, 2025.

About Pomerantz LLP

Pomerantz LLP is well-known as a leading firm specializing in corporate, securities, and antitrust class actions. Established by the late Abraham L. Pomerantz, a visionary in the realm of securities litigation, the firm has a long-standing reputation for defending the rights of individuals harmed by corporate misconduct and securities fraud. With over 85 years of experience, Pomerantz has secured numerous multi-million-dollar settlements for its clients.

For those interested in tracking developments, further details about the ongoing lawsuit and how to participate can be found at www.pomerantzlaw.com. As always, please note that prior results do not guarantee similar outcomes.

Contact Information

If you have suffered losses and wish to explore your options further, do not hesitate to connect with Pomerantz LLP. Those affected by Ardent's financial troubles may find that this lawsuit offers a pathway to recouping some of their losses. Ardent's investors should act promptly as deadlines approach.

Stay informed and take action where necessary to safeguard your investments.